These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 18350717)

  • 1. [Proinflammatory cytokines in cardiovascular diseases as potential therapeutic target].
    Bielecka-Dabrowa A; Wierzbicka M; Goch JH
    Wiad Lek; 2007; 60(9-10):433-8. PubMed ID: 18350717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammation and chronic heart failure-potential therapeutic role of intravenous immunoglobulin.
    Aukrust P; Yndestad A; Damås JK; Gullestad L
    Autoimmun Rev; 2004 Mar; 3(3):221-7. PubMed ID: 15110235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cytokine network in heart failure: pathogenetic importance and potential therapeutic targets.
    Gullestad L; Aukrust P
    Heart Fail Monit; 2001; 2(1):8-13. PubMed ID: 12634893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review of trials in chronic heart failure showing broad-spectrum anti-inflammatory approaches.
    Gullestad L; Aukrust P
    Am J Cardiol; 2005 Jun; 95(11A):17C-23C; discussion 38C-40C. PubMed ID: 15925560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Role of inflammation mediators in the pathogenesis of heart failure].
    Boglioni FV; Metra M; Locati M; Nodari S; Bontempi L; Garbellini M; Doni A; Peri G; Mantovani A
    Ital Heart J Suppl; 2001 Jun; 2(6):628-33. PubMed ID: 11460836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune activation in chronic heart failure.
    Torre-Amione G
    Am J Cardiol; 2005 Jun; 95(11A):3C-8C; discussion 38C-40C. PubMed ID: 15925558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokines and cardiovascular disease.
    Mehra VC; Ramgolam VS; Bender JR
    J Leukoc Biol; 2005 Oct; 78(4):805-18. PubMed ID: 16006537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for activation of immune system in heart failure: is there a role for anti-inflammatory therapy?
    Celis R; Torre-Martinez G; Torre-Amione G
    Curr Opin Cardiol; 2008 May; 23(3):254-60. PubMed ID: 18382215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular and oral disease interactions: what is the evidence?
    Ford PJ; Yamazaki K; Seymour GJ
    Prim Dent Care; 2007 Apr; 14(2):59-66. PubMed ID: 17462139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role of immune inflammatory activity in chronic heart failure progress].
    Mamamtavrishvili ND; Kvirkveliia AA; Abashidze RI; Sharashidze NS; Narsiia EV
    Georgian Med News; 2008; (160-161):30-4. PubMed ID: 18711234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokines and acute heart failure.
    Chen D; Assad-Kottner C; Orrego C; Torre-Amione G
    Crit Care Med; 2008 Jan; 36(1 Suppl):S9-16. PubMed ID: 18158483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Innate inflammation in myocardial perfusion and its implication for heart failure.
    Picano E; Morales MA; del Ry S; Sicari R
    Ann N Y Acad Sci; 2010 Oct; 1207():107-15. PubMed ID: 20955433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunactivation in chronic heart failure. Inflammatory mediators].
    Genth-Zotz S; von Haehling S; Blankenberg S
    Z Kardiol; 2004; 93 Suppl 4():IV24-30. PubMed ID: 15085363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinicoimmunological disorders in patients with postinfarction left ventricular remodeling and chronic cardiac failure].
    Teplliakov AT; Bolotskaia LA; Dibirov MM; Stepacheva TA; Karaman NV; Vdovina TV; Shilov SN; Kuznetsova AV
    Ter Arkh; 2008; 80(11):52-7. PubMed ID: 19143193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atorvastatin enhances interleukin-10 levels and improves cardiac function in rats after acute myocardial infarction.
    Stumpf C; Petzi S; Seybold K; Wasmeier G; Arnold M; Raaz D; Yilmaz A; Daniel WG; Garlichs CD
    Clin Sci (Lond); 2009 Jan; 116(1):45-52. PubMed ID: 18459941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of inflammatory cytokines and chemoattractants in the rat model of streptozotocin-induced diabetic heart failure.
    Drimal J; Knezl V; Navarova J; Nedelcevova J; Paulovicova E; Sotnikova R; Snirc V; Drimal D
    Endocr Regul; 2008 Sep; 42(4):129-35. PubMed ID: 18999900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of immune and inflammatory systems in chronic heart failure: novel therapeutic approaches.
    Gong KZ; Song G; Spiers JP; Kelso EJ; Zhang ZG
    Int J Clin Pract; 2007 Apr; 61(4):611-21. PubMed ID: 17394435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of intravenous immunoglobulin in the treatment of chronic heart failure.
    Aukrust P; Yndestad A; Ueland T; Damås JK; Frøland SS; Gullestad L
    Int J Cardiol; 2006 Sep; 112(1):40-5. PubMed ID: 16893578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammasomes and rheumatic diseases: evolving concepts.
    Sidiropoulos PI; Goulielmos G; Voloudakis GK; Petraki E; Boumpas DT
    Ann Rheum Dis; 2008 Oct; 67(10):1382-9. PubMed ID: 17921182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cardioangioimmunology: the immune implications in the principle cardiovascular pathologies].
    Lissoni P; Barni S; Mauri O; Pelizzoni F; Pittalis S; Osculati G; Valagussa F
    G Ital Cardiol; 1991 Oct; 21(10):1139-46. PubMed ID: 1804753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.